[1,2] The trial design This was a withdrawal design, not a simple efficacy comparison
Most patients continue statin therapy while taking semaglutide
Current EMA regulations would treat synthetic semaglutide as a generic and recombinant as a biosimilar, whereas the FDA treats any peptide chains of under 40 peptide residues as a generic, of which semaglutide (31 amino acids) and tirzepatide (39 amino acids) qualify
Clinical trials have demonstrated significant reductions in hemoglobin A1c levels in patients with type 2 diabetes, as well as substantial weight loss in individuals treated for obesity
Members access evidence-based guides, detailed protocol databases, dosing calculators, and a community of thousands who have navigated these exact questions
Frequently Asked Questions Doctor-Guided Medical Weight Loss Learn how prescription GLP-1 medications like semaglutide or tirzepatide may support weight loss when guided by a licensed medical provider and tailored to your health history.